Results
|
|
1941.
|
|
|
|
1942.
|
|
|
|
1943.
|
10-Hydroxy-7,8-dihydropyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-1,9(2H,6H)-diones: potent, orally bioavailable HIV-1 integrase strand-transfer inhibitors with activity against integrase mutants. [electronic resource] by
- Wiscount, Catherine M
- Williams, Peter D
- Tran, Lekhanh O
- Embrey, Mark W
- Fisher, Thorsten E
- Sherman, Vanessa
- Homnick, Carl F
- Donnette Staas, D
- Lyle, Terry A
- Wai, John S
- Vacca, Joseph P
- Wang, ZiQiang
- Felock, Peter J
- Stillmock, Kara A
- Witmer, Marc V
- Miller, Michael D
- Hazuda, Daria J
- Day, Alysha M
- Gabryelski, Lori J
- Ecto, Linda T
- Schleif, William A
- DiStefano, Daniel J
- Kochansky, Christopher J
- Anari, M Reza
Producer: 20081124
In:
Bioorganic & medicinal chemistry letters vol. 18
Availability: No items available.
|
|
|
1944.
|
|
|
|
1945.
|
|
|
|
1946.
|
|
|
|
1947.
|
|
|
|
1948.
|
Double-Winged 3-Hydroxypyrimidine-2,4-diones: Potent and Selective Inhibition against HIV-1 RNase H with Significant Antiviral Activity. [electronic resource] by
- Vernekar, Sanjeev Kumar V
- Tang, Jing
- Wu, Bulan
- Huber, Andrew D
- Casey, Mary C
- Myshakina, Nataliya
- Wilson, Daniel J
- Kankanala, Jayakanth
- Kirby, Karen A
- Parniak, Michael A
- Sarafianos, Stefan G
- Wang, Zhengqiang
Producer: 20170811
In:
Journal of medicinal chemistry vol. 60
Availability: No items available.
|
|
|
1949.
|
|
|
|
1950.
|
|
|
|
1951.
|
|
|
|
1952.
|
Safety and efficacy at 240 weeks of different raltegravir formulations in children with HIV-1: a phase 1/2 open label, non-randomised, multicentre trial. [electronic resource] by
- Nachman, Sharon
- Alvero, Carmelita
- Teppler, Hedy
- Homony, Brenda
- Rodgers, Anthony J
- Graham, Bobbie L
- Fenton, Terence
- Frenkel, Lisa M
- Browning, Renee S
- Hazra, Rohan
- Wiznia, Andrew A
Producer: 20190429
In:
The lancet. HIV vol. 5
Availability: No items available.
|
|
|
1953.
|
|
|
|
1954.
|
|
|
|
1955.
|
|
|
|
1956.
|
|
|
|
1957.
|
|
|
|
1958.
|
|
|
|
1959.
|
|
|
|
1960.
|
|